P

PBE

Invesco Biotechnology & Genome ETF

83.8 0 USD

-0.12%

Сектор: Финансы

Базовая: USD

Валюта прибыли: USD

Дневной диапазон

Годовой диапазон

Дневное изменение

-0.12%

Месячное изменение

+5.62%

6-месячное изменение

+2.28%

Годовое изменение

+34.58%

Предыдущее закрытие

83.9 0

Open

83.7 9

Low

83.7 4

High

83.8 0

Volume

4

Открыть полный график Full chart

Обзор Все активы Тепловая карта

Ключевые активы Market Value Shares Weight %

COLL Collegium Pharmaceutical, Inc. 7.14 M 155.58 K 2.72%

EXEL Exelixis, Inc. 6.94 M 167.82 K 2.64%

HALO Halozyme Therapeutics, Inc. 6.87 M 95.82 K 2.61%

BCRX BioCryst Pharmaceuticals, Inc. 6.83 M 1.04 M 2.60%

NBIX Neurocrine Biosciences, Inc. 6.83 M 50.20 K 2.60%

PTCT PTC Therapeutics, Inc. 6.71 M 88.82 K 2.55%

PTGX Protagonist Therapeutics, Inc. 6.61 M 80.86 K 2.52%

VCEL Vericel Corp. 6.56 M 182.37 K 2.50%

TGTX TG Therapeutics, Inc. 6.52 M 221.37 K 2.48%

RGEN Repligen Corp. 6.33 M 42.39 K 2.41%

MDGL Madrigal Pharmaceuticals, Inc. 5.90 M 12.06 K 2.24%

VCYT Veracyte, Inc. 5.78 M 151.83 K 2.20%

Invesco Government & Agency Portfolio 188.76 K 188.76 K 0.07%

1
2

Новости

First Quarter Earnings: Sharpening Sector Divergence

3 Reasons To Stick With Growth Stocks In Rotating Markets

Seeking Innovation Beyond Tech? Insight On Healthcare Stocks

Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts

What's The Dominant Trend In Earnings: AI Or Geopolitics?

Medical Technology Stocks: Innovation Endures As Valuations Reset

AI And The Future Of Healthcare

Global PMI: Tracking The Sectors Hit Hardest By The Middle East War

Can Forgotten Biotech Break Out?

Concerns Shift From Obsolescence To Oil

Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?

CDT Insider Sentiment March 2026: The Probability Race And Barbell Strategies